Novartis Ag NVS
NYSE NVS
$146.91 +1.45 (+1.00%)
As of: Sep 28, 2026 · 3:59 PM EDT

Novartis Ag (NVS) Long-Term Debt Issuances (2017 - 2026)

Updated

Novartis Ag's Long-Term Debt Issuances was $1.98 billion in Q2 2026.

Analysis

Novartis Ag (NVS) Long-Term Debt Issuances (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Novartis Ag's Long-Term Debt Issuances was $4.46 billion through Jun 30, 2026; for FY2025, it was $6.1 billion, down 0.7% from FY2024.

  • Long-Term Debt Issuances shows a five-year compound annual growth rate of -3.1% (FY2020 to FY2025).
  • In earlier years, Long-Term Debt Issuances was $6.14 billion in FY2024, $16 million in FY2022 (unchanged) and $16 million in FY2021 (-99.8%).
  • The Q2 2026 figure marks the highest quarterly Long-Term Debt Issuances since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.98 Bn
Jun 30, 2024 2.47 Bn
Jun 30, 2023 4.00 Mn
Jun 30, 2022 3.00 Mn
Jun 30, 2019 -91.00 Mn
Jun 30, 2018 91.00 Mn
Jun 30, 2017 2.00 Mn
API Access

Novartis Ag Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=NVS&period=max&api_key=YOUR_API_KEY